Neurologists' attitudes regarding rt-PA for acute ischemic stroke

被引：19
|
作者：
Villar-Cordova, C
Morgenstern, LB
Barnholtz, JS
Grotta, JC
机构：
[1] Univ Texas, Sch Med, Dept Neurol, Houston, TX 77030 USA
[2] Univ Texas, Sch Publ Hlth, Dept Biometry, Houston, TX 77025 USA
[3] Univ Texas, Sch Publ Hlth, Epidemiol Res Ctr, Houston, TX 77025 USA
来源：
NEUROLOGY | 1998年 / 50卷 / 05期
关键词：
D O I：
10.1212/WNL.50.5.1491
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
We studied the attitudes of 238 Texas neurologists regarding the use of recombinant tissue plasminogen activator (rt-PA). The results show that 38 (16%) had treated stroke patients with rt-PA, and 97% of these would do so again. In the group that had not treated patients, 60% would treat if a suitable candidate presented. We conclude that soon after FDA approval of rt-PA, two-thirds of survey respondents were using or were planning to use this therapy. Those neurologists who have used ct-PA for stroke report a positive experience.
引用
收藏
页码：1491 / 1494
页数：4
相关论文
共 50 条
  • [21] Cost-effectiveness of thrombolysis with RT-PA for acute ischemic stroke in Taiwan
    Tseng, MC
    Chang, KC
    VALUE IN HEALTH, 2004, 7 (06) : 789 - 789
  • [22] Eligibility for rt-PA in acute ischemic stroke: A population-based study
    Kleindorfer, D
    Alwell, K
    Khoury, J
    Miller, R
    Kissela, BM
    Schneider, A
    Woo, D
    Pancioli, A
    Jauch, E
    Szaflarski, J
    Gebel, JM
    Shukla, R
    Moomaw, C
    Broderick, JP
    STROKE, 2003, 34 (01) : 281 - 281
  • [23] Risk of immediate heparin after rt-PA therapy in acute ischemic stroke
    Grond, M
    Rudolf, J
    Neveling, M
    Stenzel, C
    Heiss, WD
    CEREBROVASCULAR DISEASES, 1997, 7 (06) : 318 - 323
  • [24] Open label rt-PA therapy for acute ischemic stroke: The Calgary experience
    Demchuk, A
    Hoyte, K
    Newcommon, N
    Klein, G
    Buchan, A
    NEUROLOGY, 1997, 48 (03) : 33005 - 33005
  • [25] US Geographic Distribution of rt-PA Utilization by Hospital for Acute Ischemic Stroke
    Kleindorfer, Dawn
    Xu, Yingying
    Moomaw, Charles J.
    Khatri, Pooja
    Adeoye, Opeolu
    Hornung, Richard
    STROKE, 2009, 40 (11) : 3580 - 3584
  • [26] Effect of elevated hemostatic markers on outcome after rt-PA therapy for acute ischemic stroke: Results from the NINDS rt-PA stroke trial
    Tanne, D
    Macko, RF
    Lin, H
    Tilley, BC
    Levine, SR
    STROKE, 2006, 37 (02) : 704 - 704
  • [27] Antiphospholipid-protein antibodies and acute ischemic stroke in the NINDS rt-PA Stroke Trial
    Tanne, D
    Levine, SR
    Brey, RL
    Lin, H
    Tilley, BC
    NEUROLOGY, 2003, 61 (08) : 1158 - U18
  • [28] Therapy for acute ischemic stroke: The door opens - Interpreting the NINDS RT-PA stroke study
    Sila, CA
    Furlan, AJ
    CLEVELAND CLINIC JOURNAL OF MEDICINE, 1996, 63 (02) : 77 - 79
  • [29] DERrAME: Disparities Among Ethnicities Regarding rt-PA in Acute Stroke Management and Evaluations
    Nguyen, David T.
    Ho, James P.
    Pirastehfar, Mohsen
    Narula, Rajiv
    Hailey, Lovella
    Mortin, Melissa
    Rapp, Karen
    Agrawal, Kunal
    Huisa, Branko
    Modir, Royya
    Meyer, Dawn
    Hemmen, Thomas
    STROKE, 2017, 48
  • [30] Contraindications and Exclusion Criteria in Guidelines for Rt-pa in Acute Ischemic Stroke: Can the New Aha/asa Guideline Expand the Use of Rt-pa?
    Nathaniel, Thomas I.
    Williams, Jessica-Ashley
    Fazzone, Brian
    Yi, Sara
    Morris, Gabrielle
    Black, Leigh-Ann
    Fredwall, Megan
    Staford, Clay
    Adkins, Alyssa
    Polk, Shuler
    HYPERTENSION, 2016, 68
12345